Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 1863 entries
View as:

Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00004249 Org: User:
Start: 08/31/98 End: 11/30/01 Due: 11/30/02

Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03667482 Org: User:
Start: 09/07/18 End: 07/17/24 Due: 07/17/25

Pyroxamide in Treating Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00042900 Org: User:
Start: 04/30/02 End: 09/30/02 Due: 09/30/03

Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00526292 Org: User:
Start: 08/31/07 End: 07/31/15 Due: 07/31/16

Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT01974804 Org: User:
Start: 10/25/13 End: 12/28/22 Due: 12/28/23

Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L

Phase: N/A Priority: Normal
NCT ID: NCT00807599 Org: User:
Start: 12/10/08 End: 07/31/18 Due: 07/31/19

Immunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL)

Phase: N/A Priority: Normal
NCT ID: NCT02494206 Org: User:
Start: 07/31/15 End: 05/31/18 Due: 05/31/19

Colorectal Cancer Survivors' Needs and Preferences for Survivorship Information

Phase: N/A Priority: Normal
NCT ID: NCT01003600 Org: User:
Start: 10/31/09 End: 11/30/14 Due: 11/30/15

Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00002502 Org: User:
Start: 07/31/92 End: 05/31/00 Due: 05/31/01

Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00074100 Org: User:
Start: 08/31/03 End: 09/30/04 Due: 09/30/05

Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging

Phase: N/A Priority: Normal
NCT ID: NCT01482741 Org: User:
Start: 11/30/11 End: 06/30/15 Due: 06/30/16

Behavioral Intervention For BMT/SCT Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00579917 Org: User:
Start: 01/31/05 End: 12/31/08 Due: 12/31/09

A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT03033303 Org: User:
Start: 01/23/17 End: 06/30/25 Due: 06/30/26

A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05004116 Org: User:
Start: 08/09/21 End: 08/31/28 Due: 08/31/29

GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01239251 Org: User:
Start: 11/30/10 End: 11/30/11 Due: 11/30/12

Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00450827 Org: User:
Start: 08/31/06 End: 08/31/15 Due: 08/31/16

BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)

Phase: N/A Priority: Normal
NCT ID: NCT01453595 Org: User:
Start: 10/31/11 End: 04/30/14 Due: 04/30/15

Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03289195 Org: User:
Start: 09/18/17 End: 09/30/25 Due: 09/30/26

Improving Clinical PET/CT Image Quality in Retrospectively Reconstructed Breath-Hold Images

Phase: N/A Priority: Normal
NCT ID: NCT01109953 Org: User:
Start: 04/30/10 End: 03/31/12 Due: 03/31/13

Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00036972 Org: User:
Start: 11/30/01 End: 12/31/09 Due: 12/31/10

Community Primary Care Providers to Implement and Disseminate Cancer Prevention Interventions for Latino Populations

Phase: N/A Priority: Normal
NCT ID: NCT01803750 Org: User:
Start: 02/28/13 End: 02/28/15 Due: 02/28/16

Trial of YUMI Uterine Manipulator

Phase: N/A Priority: Normal
NCT ID: NCT02923544 Org: User:
Start: 09/27/16 End: 05/03/22 Due: 05/03/23

Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03158064 Org: User:
Start: 05/15/17 End: 11/30/25 Due: 11/30/26

Retrospective Review of Esophageal Cancer at MSKCC

Phase: N/A Priority: Normal
NCT ID: NCT05706558 Org: User:
Start: 12/13/16 End: 02/28/26 Due: 02/28/27

A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02989584 Org: User:
Start: 12/20/16 End: 12/31/25 Due: 12/31/26